Another study showed that MSLN can enhance the invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways, blocking the MSLN-related pathway may be a potential strategy to improve the prognosis of ovarian cancer patients 325. This evidence concerns the gene MMP7 and ovarian carcinoma.